EVA pharma

Senior R&D Scientist - Inhalation Development

EVA pharma  •  Giza, EG (Onsite)  •  2 hours ago
Apply
AI can make mistakes so check important info. Chat history is never stored.

Job Description

EVA Pharma is hiring Senior Scientist for the inhalation development team. The role will be responsible for hands-on formulation development, analytical characterisation, scale-up, and process validation of Generic Dry Powder Inhaler products — including capsule-based, blister-based, reservoir-based, dual capsule/blister inhalers, and generic nebulizers.

The role requires deep technical expertise in powder engineering and inhalation science, with the ability to independently drive development activities.

Key responsibilities:

DPI Formulation Development

  • Design and optimise DPI, MDI & Nebulizer formulations for capsule-based, blister-based, reservoir-based, and dual capsule/blister inhalers
  • Develop and evaluate device-formulation compatibility across all inhalation platform types
  • Apply particle engineering techniques — micronization, spray drying, powder blending — to achieve target aerodynamic profiles
  • Develop generic nebulizer formulations alongside DPI programmes
  • Execute feasibility, prototype, and optimisation studies with full scientific documentation

Analytical Characterisation

  • Perform aerodynamic characterisation using NGI and DUSA for in-process and release testing
  • Apply laser diffraction and other particle sizing tools to characterise powder properties
  • Execute and interpret analytical data to guide formulation decisions and device selection
  • Support development and qualification of analytical methods specific to inhalation products

Scale-Up & Process Validation

  • Lead scale-up activities from lab to pilot and commercial manufacturing scale
  • Define and optimise critical process parameters using QbD principles, DoE, and FMEA
  • Execute process validation protocols and compile validation reports
  • Identify and mitigate technical risks through the development lifecycle

Tech Transfer to Manufacturing

  • Prepare technology transfer packages including formulation, process, and analytical documentation
  • Support on-site transfer activities at manufacturing scale and resolve technical deviations
  • Collaborate with production and engineering teams to ensure successful handover

Bioequivalence Support

  • Contribute to bioequivalence protocol design for generic DPI products versus reference innovators
  • Prepare formulation and device rationale sections required for BE study initiation
  • Support interpretation of BE data from a formulation science perspective

Scientific Guidance

  • Provide day-to-day technical guidance to 1–3 junior researchers working on DPI projects
  • Review experimental data, troubleshoot issues, and validate scientific conclusions
  • Maintain up-to-date knowledge of inhalation science, device technologies, and industry trends

Requirements

Education:

PhD or Master's degree in Pharmaceutics, Pharmaceutical Sciences, or related field

Overall Experience:

8–10 years of hands-on experience in DPI development within the pharmaceutical industry

Technical skills:

  • Proven formulation experience across capsule-based, blister-based, reservoir-based, and dual DPI formats
  • Hands-on expertise with NGI, DUSA, and laser diffraction for aerodynamic characterisation
  • Particle engineering skills: micronization, spray drying, and powder blending
  • Scale-up and process validation experience for inhalation products
  • Experience preparing technology transfer documentation for manufacturing handover
  • Contribution to BE protocol design or study initiation for generic DPI products
  • Familiarity with QbD, DoE, and FMEA-based risk management
EVA pharma

About EVA pharma

EVA Pharma is dedicated to improving access to affordable, high-quality medicines around the world, focusing on three core pillars: innovation, development and sustainable access. The company leverages cutting-edge technology at two research centers bringing first-of-its-kind capabilities to the Middle East and Africa including mRNA research and development from AI prediction to biological products.

With a 5,000-strong team of professionals, EVA Pharma produces more than one million healthcare products a day at four state-of-the-art manufacturing facilities, which are internationally recognized for innovation, and have been approved by multiple regulatory agencies.

Guided by a relentless drive to ensure sustainable access to pressing yet unmet disease areas, the company’s product portfolio focuses on twelve therapeutic areas: Anti-infectives, metabolic health, bone, neuroscience, oncology, respiratory, gynecology, urology and andrology, pediatrics, ophthalmology, gastrointestinal tract, family medicine to meet both local and international demand.

EVA Pharma is one of the fastest-growing healthcare companies in the Middle East and Africa, with an extensive pan-African presence, while operating in more than 60 countries worldwide.

Industry
Chemicals & Materials
Company Size
5,001-10,000 employees
Headquarters
Haram, EG
Year Founded
1997
Social Media